CMS STATEMENT: Delay in Final Chimeric Antigen Receptor (CAR) T-cell therapy National Coverage Determination

May 17, 2019 | Coverage

Delay in Final Chimeric Antigen Receptor (CAR) T-cell therapy National Coverage Determination

From a CMS spokesperson:

“CMS will not be issuing a final National Coverage Determination on CAR T-cell therapy for cancer today, but a decision is forthcoming.”

To read the proposed decision, visit the CMS website at:

https://www.cms.gov/medicare-coverage-database/details/nca-tracking-sheet.aspx?NCAId=291

Comments may be viewed in their entirety by using the following link:

https://www.cms.gov/medicare-coverage-database/details/nca-view-public-comments.aspx?NCAId=291.

###

Get CMS news at cms.gov/newsroom, sign up for CMS news via email and follow CMS on Twitter CMS Administrator @SeemaCMS, @CMSgov, and @CMSgovPress.